Skip to main content
Hualan Biological Engineering Inc. logo

Hualan Biological Engineering Inc. — Investor Relations & Filings

Ticker · 002007 ISIN · CNE000001JN8 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,526 across all filing types
Latest filing 2022-10-30 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 002007

About Hualan Biological Engineering Inc.

https://www.hualanbio.com

Hualan Biological Engineering Inc. is a biopharmaceutical enterprise specializing in the research, development, production, and commercialization of blood products and vaccines. The company’s portfolio is divided into two primary segments: plasma-derived therapeutics and viral vaccines. Key blood products include human albumin, intravenous immunoglobulin (IVIG), human coagulation factor VIII, and prothrombin complex. In the vaccine sector, the company produces seasonal influenza vaccines, including quadrivalent formulations, as well as hepatitis B and rabies vaccines. Hualan Biological Engineering operates advanced manufacturing facilities and plasma collection centers, focusing on high-quality standards and technological innovation in recombinant protein drugs and monoclonal antibodies to address critical medical needs in immunology, hematology, and infectious disease prevention.

Recent filings

Filing Released Lang Actions
投资者关系管理制度
Governance Information Classification · 95% confidence The document is titled "投资者关系管理制度" which translates to "Investor Relations Management System". It details the company's policies, principles, and procedures for managing investor relations, including communication with investors, information disclosure, handling investor complaints, and regulatory compliance. It does not contain financial statements, earnings data, or audit information. It is a governance-related document outlining internal rules and practices for investor relations management. Therefore, it fits best under Governance Information (CGR). The document length (7811 characters) and content confirm it is a detailed policy document rather than a brief announcement or report publication notice.
2022-10-30 Chinese
半年度非经营性资金占用及其他关联资金往来情况汇总表
Interim / Quarterly Report Classification · 90% confidence The document is a summary table detailing non-operating fund occupation and other related party fund transactions for the half-year period of 2022. It contains specific financial data such as beginning balances, amounts incurred, interest, repayments, and ending balances for related parties and subsidiaries. The document is focused on financial data for a half-year period and is not a brief announcement or a certification. It is not a full annual report but rather a report covering a period shorter than a full fiscal year with substantive financial data. Therefore, it fits the definition of an Interim / Quarterly Report (IR). The document length is 1852 characters, which is short but contains actual financial data, so it is not a report publication announcement or regulatory filing. Hence, the classification is IR with high confidence. H1 2022
2022-08-22 Chinese
2022年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as the '2022 年半年度报告全文' which translates to '2022 Semi-Annual Report Full Text'. It contains detailed financial data, management discussion and analysis, company overview, financial indicators, and other comprehensive information typical of an interim or quarterly report. The document length is 15,000 characters, indicating it is a full report rather than a brief announcement. It includes actual financial statements and substantive financial data for the half-year period ending June 30, 2022. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2022
2022-08-22 Chinese
独立董事关于控股股东及其他关联方占用公司资金、公司对外担保情况的专项说明和独立意见
Regulatory Filings Classification · 95% confidence The document is an independent opinion from independent directors regarding specific matters discussed at the company's eighth board of directors' second meeting. It focuses on compliance with regulations about related party transactions and external guarantees, referencing regulatory bodies and laws. The content is a formal opinion or statement rather than a full report or financial statement. The document length is short (582 characters), and it does not contain financial statements or detailed financial data. It is not an announcement of voting results, management changes, or a call transcript. It fits best as a Regulatory Filing (RNS) because it is a compliance-related statement that does not fit other specific categories.
2022-08-22 Chinese
2022年半年度报告摘要
Interim / Quarterly Report Classification · 95% confidence The document is titled as a "2022 年半年度报告摘要" which translates to "2022 Semi-Annual Report Summary." It contains detailed financial data such as revenue, net profit, earnings per share, total assets, and shareholder information for the half-year period. The document includes financial metrics comparing the current period to the previous year, which is typical of an interim or quarterly report. The length of the document is 2483 characters, which is relatively short but contains substantive financial data and analysis, not just an announcement or summary. It is not a full annual report (10-K), nor is it a brief earnings release or a regulatory filing. The presence of detailed financial figures and performance indicators for a half-year period aligns with the definition of an Interim / Quarterly Report (IR). H1 2022
2022-08-22 Chinese
关于获批设置单采血浆站的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement from a company about receiving approval to set up plasma collection stations. It contains no financial data, no report or presentation, and is not related to voting, management changes, or legal proceedings. It is a regulatory announcement about operational approval. The document length is only 491 characters, indicating it is a brief announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other categories.
2022-07-12 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.